[PE33] Poster Session 33
Treatment for adult asthma 2

[PE33-17] Mepolizumab 100 mg/4 weeks as a maintenance therapy in patients affected by EGPA and severe steroid-dependent asthma with systemic vasculitis in remission phase

Marco Caminati¹, Alessandro Giollo², Giovanni Orsolini², Giuliana Festi³, Claudio Micheletto³, Matteo Maule⁴, Claudio Lunardi⁴, Gianenrico Senna¹ (1.Department of Medicine, University of Verona; Allergy Unit and Asthma Center, Verona University Hospital, Italy, 2.Division of Rheumatology, Department of Medicine, University and Azienda Ospedaliera Universitaria Integrata of Verona, Italy, 3.Cardio-Thoracic Department, Respiratory Unit, Integrated University Hospital, Italy, 4.Department of Medicine, University of Verona, Italy)